A 19–34-GHz Bridged-T Phase Shifter With High-Pass Phase Compensation Achieving 3.9° RMS Phase Error for 5G NR ...

Keros will also be eligible to receive tiered royalties on net sales. About the Elritercept Phase 3 RENEW Clinical Trial The elritercept Phase 3 RENEW clinical trial (NCT06499285) is a global, ...

MALVERN, Pa., July 18, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that ...

LAS VEGAS, July 17, 2025 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company has recently received a major delivery of additional ...

This equipment will be used for both Phase 1 and Phase 2 of the planned testing at the Demonstration Facility.

Tonix Pharmaceuticals has announced the publication of its Phase 3 RESILIENT trial results for TNX-102 SL, a sublingual formulation of cyclobenzaprine for treating fibromyalgia. The data shows ...